Drugs / Montmorrillonite
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04479202 Comparator | Feb → Apr 2020 | COVID-19 | Chinese Medical Association | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Montmorrillonite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04479202 ↗ |
| Route | Oral | “However, if the patient has diarrhea symptoms, montmorillonite powder should be given orally.” NCT04479202 ↗ |